The biology of small leucine-rich proteoglycans in bone pathophysiology

145Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The class of small leucine-rich proteoglycans (SLRPs) is a family of homologous proteoglycans harboring relatively small (36-42 kDa) protein cores compared with the larger cartilage and mesenchymal proteoglycans. SLRPs have been localized to most skeletal regions, with specific roles designated during all phases of bone formation, including periods relating to cell proliferation, organic matrix deposition, remodeling, and mineral deposition. This is mediated by key signaling pathways regulating the osteogenic program, including the activities of TGF-β, bone morphogenetic protein, Wnt, and NF-κB, which influence both the number of available osteogenic precursors and their subsequent development, differentiation, and function. On the other hand, SLRP depletion is correlated with degenerative diseases such as osteoporosis and ectopic bone formation. This minireview will focus on the SLRP roles in bone physiology and pathology.

Cite

CITATION STYLE

APA

Nikitovic, D., Aggelidakis, J., Young, M. F., Iozzo, R. V., Karamanos, N. K., & Tzanakakis, G. N. (2012, October 5). The biology of small leucine-rich proteoglycans in bone pathophysiology. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.R112.379602

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free